Iron deficiency anemia is a condition in which the body does not have enough iron to produce hemoglobin, the protein that carries oxygen in red blood cells. Iron deficiency anemia can be caused by a lack of iron in the diet, heavy menstrual periods, or chronic bleeding from ulcers or other conditions. The global iron deficiency anemia therapy market is expected to grow at a CAGR of 5.5% during the forecast period (2017-2030).
The global iron deficiency anemia therapy market is segmented on the basis of type into oral iron therapy, parenteral iron therapy, and red blood cell transfusion; on the basis of application into hospitals and clinics; and on the basis of region into North America, Latin America, Europe, Asia Pacific and Middle East & Africa. The oral iron therapy segment accounted for over 50% share in 2017 owing to its ease of use as compared to parenteral therapies such as intravenous administration or intramuscular injection. Oral therapies are also preferred due to their lower cost as compared with other therapies such as red blood cell transfusion which are expensive due to their high cost associated with donor acquisition costs and storage costs.
- Increasing prevalence of iron deficiency anemia in developing countries such as India and China is one of the major factors driving the growth of this market.
- Increasing awareness about iron deficiency anemia among people and physicians is also driving the growth of this market.
- The increasing number of women who are pregnant or breastfeeding, which increases their risk for iron deficiency anemia, is also driving the growth of this market.
- The increasing number of people with chronic diseases such as diabetes mellitus type 2 and chronic kidney disease are also driving the growth rate.
Industry Growth Insights published a new data on “Iron Deficiency Anemia Therapy Market”. The research report is titled “Iron Deficiency Anemia Therapy Market research by Types (Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion, Other, Iron Deficiency Anemia Therap), By Applications (Hospitals, Clinics, Home Healthcare, Other), By Players/Companies Allergan, AMAG Pharmaceuticals, Integra Lifesciences, Galderma Pharma, Teoxane, Sinclair Pharma, Pieris, Pharmacosmos AS, Johnson & Johnson, Luitpold Pharmaceuticals, Keryx Biopharmaceuticals, Vifor Pharma, Akebia Therapeutics, Iron Deficiency Anemia Therap”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Iron Deficiency Anemia Therapy Market Research Report
By Type
Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion, Other, Iron Deficiency Anemia Therap
By Application
Hospitals, Clinics, Home Healthcare, Other
By Companies
Allergan, AMAG Pharmaceuticals, Integra Lifesciences, Galderma Pharma, Teoxane, Sinclair Pharma, Pieris, Pharmacosmos AS, Johnson & Johnson, Luitpold Pharmaceuticals, Keryx Biopharmaceuticals, Vifor Pharma, Akebia Therapeutics, Iron Deficiency Anemia Therap
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Iron Deficiency Anemia Therapy Market Report Segments:
The global Iron Deficiency Anemia Therapy market is segmented on the basis of:
Types
Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion, Other, Iron Deficiency Anemia Therap
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Home Healthcare, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- AMAG Pharmaceuticals
- Integra Lifesciences
- Galderma Pharma
- Teoxane
- Sinclair Pharma
- Pieris
- Pharmacosmos AS
- Johnson & Johnson
- Luitpold Pharmaceuticals
- Keryx Biopharmaceuticals
- Vifor Pharma
- Akebia Therapeutics
- Iron Deficiency Anemia Therap
Highlights of The Iron Deficiency Anemia Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Iron Therapy
- Parenteral Iron Therapy
- Red Blood Cell Transfusion
- Other
- Iron Deficiency Anemia Therap
- By Application:
- Hospitals
- Clinics
- Home Healthcare
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Iron Deficiency Anemia Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Iron deficiency anemia is a condition in which the body does not have enough iron. Iron deficiency can be caused by a lack of dietary iron, blood loss, or illness. Treatment for iron deficiency anemia includes supplements and/or surgery to remove blood from the body and give it back to the patient through transfusions.
Some of the key players operating in the iron deficiency anemia therapy market are Allergan, AMAG Pharmaceuticals, Integra Lifesciences, Galderma Pharma, Teoxane, Sinclair Pharma, Pieris, Pharmacosmos AS, Johnson & Johnson, Luitpold Pharmaceuticals, Keryx Biopharmaceuticals, Vifor Pharma, Akebia Therapeutics, Iron Deficiency Anemia Therap.
The iron deficiency anemia therapy market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Iron Deficiency Anemia Therapy Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Iron Deficiency Anemia Therapy Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Iron Deficiency Anemia Therapy Market - Supply Chain
4.5. Global Iron Deficiency Anemia Therapy Market Forecast
4.5.1. Iron Deficiency Anemia Therapy Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Iron Deficiency Anemia Therapy Market Size (000 Units) and Y-o-Y Growth
4.5.3. Iron Deficiency Anemia Therapy Market Absolute $ Opportunity
5. Global Iron Deficiency Anemia Therapy Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Type
5.3.1. Oral Iron Therapy
5.3.2. Parenteral Iron Therapy
5.3.3. Red Blood Cell Transfusion
5.3.4. Other
5.3.5. Iron Deficiency Anemia Therap
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Iron Deficiency Anemia Therapy Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Home Healthcare
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Iron Deficiency Anemia Therapy Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Iron Deficiency Anemia Therapy Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Iron Deficiency Anemia Therapy Demand Share Forecast, 2019-2026
9. North America Iron Deficiency Anemia Therapy Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Home Healthcare
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Type
9.7.1. Oral Iron Therapy
9.7.2. Parenteral Iron Therapy
9.7.3. Red Blood Cell Transfusion
9.7.4. Other
9.7.5. Iron Deficiency Anemia Therap
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Iron Deficiency Anemia Therapy Demand Share Forecast, 2019-2026
10. Latin America Iron Deficiency Anemia Therapy Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Home Healthcare
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Type
10.7.1. Oral Iron Therapy
10.7.2. Parenteral Iron Therapy
10.7.3. Red Blood Cell Transfusion
10.7.4. Other
10.7.5. Iron Deficiency Anemia Therap
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Iron Deficiency Anemia Therapy Demand Share Forecast, 2019-2026
11. Europe Iron Deficiency Anemia Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Home Healthcare
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Type
11.7.1. Oral Iron Therapy
11.7.2. Parenteral Iron Therapy
11.7.3. Red Blood Cell Transusion
11.7.4. Other
11.7.5. Iron Deficiency Anemia Therap
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Iron Deficiency Anemia Therapy Demand Share, 2019-2026
12. Asia Pacific Iron Deficiency Anemia Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Home Healthcare
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Type
12.7.1. Oral Iron Therapy
12.7.2. Parenteral Iron Therapy
12.7.3. Red Blood Cell Transfusion
12.7.4. Other
12.7.5. Iron Deficiency Anemia Therap
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Iron Deficiency Anemia Therapy Demand Share, 2019-2026
13. Middle East & Africa Iron Deficiency Anemia Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Home Healthcare
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Iron Deficiency Anemia Therapy Market Size and Volume Forecast by Type
13.7.1. Oral Iron Therapy
13.7.2. Parenteral Iron Therapy
13.7.3. Red Blood Cell Transfusion
13.7.4. Other
13.7.5. Iron Deficiency Anemia Therap
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Iron Deficiency Anemia Therapy Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Iron Deficiency Anemia Therapy Market: Market Share Analysis
14.2. Iron Deficiency Anemia Therapy Distributors and Customers
14.3. Iron Deficiency Anemia Therapy Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Allergan
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. AMAG Pharmaceuticals
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Integra Lifesciences
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Galderma Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Teoxane
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sinclair Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Pieris
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pharmacosmos AS
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Johnson & Johnson
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Luitpold Pharmaceuticals
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Keryx Biopharmaceuticals
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Vifor Pharma
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Akebia Therapeutics
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Iron Deficiency Anemia Therap
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
